ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,051.41
      -0.21%
      US Tech 100
      17,267.60
      0.15%
      Dow Jones
      37,798.97
      0.17%
      Brent Oil
      89.56
      -0.35%
      Bitcoin
      64,036.20
      0.97%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sesen Bio Inc (SESN)

      7. Sesen Bio Inc (SESN) News

      SESN

      Sesen Bio (SESN)

      Sesen Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SESN
      DateTimeSourceHeadlineSymbolCompany
      12:52PMiHub NewswireFeaturedCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
      08/10/20237:30AMPR Newswire (US)Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:SESNSesen Bio Inc
      03/06/202312:41PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      03/06/202312:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SESNSesen Bio Inc
      03/03/202311:07AMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:SESNSesen Bio Inc
      03/03/202311:06AMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:SESNSesen Bio Inc
      03/02/202312:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SESNSesen Bio Inc
      03/02/202311:32AMBusiness WireSesen Bio Stockholders Approve Merger with Carisma TherapeuticsNASDAQ:SESNSesen Bio Inc
      02/28/20238:08AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/28/20238:03AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SESNSesen Bio Inc
      02/28/20238:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SESNSesen Bio Inc
      02/28/20238:00AMBusiness WireSesen Bio Reports Fourth Quarter and Full-Year 2022 Financial ResultsNASDAQ:SESNSesen Bio Inc
      02/27/20234:33PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/27/20238:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SESNSesen Bio Inc
      02/21/20239:05AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/21/20239:00AMBusiness WireLeading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With CarismaNASDAQ:SESNSesen Bio Inc
      02/17/20238:18AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/17/20238:08AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/17/20238:04AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/17/20238:02AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/16/20235:06PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SESNSesen Bio Inc
      02/16/20234:46PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/16/20234:42PMBusiness WireLeading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special MeetingNASDAQ:SESNSesen Bio Inc
      02/16/20238:02AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/16/20238:00AMBusiness WireSesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending MergerNASDAQ:SESNSesen Bio Inc
      02/15/20234:55PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SESNSesen Bio Inc
      02/15/20238:02AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
      02/15/20238:00AMBusiness WireBML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma TherapeuticsNASDAQ:SESNSesen Bio Inc
      02/14/20234:40PMEdgar (US Regulatory)Registration Pursuant to Securities Act Rule 462(b) of up to an Additional 20% of Securities for an Offering That Was Registered on a Form S-4 (s-4mef)NASDAQ:SESNSesen Bio Inc
      02/14/20239:08AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SESNSesen Bio Inc
       Showing the most relevant articles for your search:NASDAQ:SESN